Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Friday, 16th May, 2025 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078, at 3:30 p.m. inter-alia to: 1. To consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended 31st March, 2025. 2. To consider and decide the appointment of Mr. Swapnil Jayesh Madiyar (DIN 08520796) as Additional (Non-promoter & Non- executive) Director of the Company As intimated vide our letter dated 29th March, 2025; the trading window for dealing in the securities of the Company is closed from Saturday, 01st April, 2025 till the second trading day after the Board meeting date i.e. 16th May, 2025 for the declaration of financial results for the quarter & financial year ended March 31, 2025.

pdf

Colinz Laboratories Ltd.

07 Apr 2025

43.29

4.82%

Company Update

Colinz Laboratories Ltd - 531210 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find the attached certificate under Regulation 74(5) of SEBI(Regulationss0 , 2018 for the Quarter ended Mar-2025 received form our RTA M/s. BIgshare Services Pvt. Ltd. Kindly take the same on records.

pdf

Colinz Laboratories Ltd.

03 Apr 2025

43.29

4.82%

Company Update

Colinz Laboratories Ltd - 531210 - Confirmation Of Not Being Identified As Large Corporate In Terms …

BSE India

with reference to the captioned subject we Colinz Laboratories Ltd (the Company) , do hereby confirm that we do not fulfill the criteria mentioned at para 2.2 of the said circular w. r. t. applicability framework for Large Corporate (LC). therefore the filing of Annual Disclosure under said circular for the Year ended 31-03-2024 does not arise.

pdf

Colinz Laboratories Ltd.

03 Apr 2025

43.29

4.82%

Company Update

Colinz Laboratories Ltd - 531210 - Non - Applicability Of Annual Secretarial Compliance Report Under Regulation …

BSE India

This is to inform you that Annual Secretarial Compliance under Regulation 24A of SEBI(LODR), Regulation, 2018, read with SEBI circular dated 8/2/2019 and BSE Circular dated 9-5-2019 and 14/5/2019is not applicable to our Company as Company is claiming exemption under Regulation 15(2) (a) of SEBI(LODR) Regulation, 2015.

pdf

Colinz Laboratories Ltd.

03 Apr 2025

43.29

4.82%

Company Update

Colinz Laboratories Ltd - 531210 - Annual Disclosure Of Encumberances Under Regulation 31(4) Of SEBI (Substantial …

BSE India

Annual Disclosure of eccumberances under Regulation 31(4) of SEBI(Substantial Acquisition of Shares and takeovers) regulation, 2011 for the year ended on 31-03-2025

pdf

Colinz Laboratories Ltd.

02 Apr 2025, 06:20PM

43.29

4.82%

Company Update

Colinz Laboratories Ltd - 531210 - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant …

BSE India

As required under Regulation 15(2) of SEBI(LODR) , Regulations,2015. Compliance with the provisions as specified in Regulation 17 to 27 and Clauses (b) to (i) and (t) and other applicable provision made thereunder SHALL NOT APLLICABLE TO THE COMPANY as the Company claiming EXEPMTION under Regulation 15(2) (a) of SEBI(LODR) Regulations, 2015. Accordingly we are submitting the NON Applicability Certificate for the Quarter ended on 31-03-2025.

pdf

Colinz Laboratories Ltd.

02 Apr 2025, 06:12PM

43.29

4.82%

Company Update

Colinz Laboratories Ltd - 531210 - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) …

BSE India

As per the Regulation 32 of SEBI(LODR) of Regulation ,2015 ( statement of Deviation or Variation for proceeds of Public issue , rights,(QIP) , is not applicable to the Company for the Quarter Ended 31-03-2025 since we have not made any Public Issue/Right Issue/Preferential issue/QIP etc.

pdf

Colinz Laboratories Ltd.

29 Mar 2025

43.29

4.82%

SAST

Colinz Laboratories Ltd - 531210 - Closure of Trading Window

BSE India

WE WOULD LIKE TO INFORM PURSUANT TO THE COMPANYS CODE OF CONDCT FOR INSIDER TRADING READ WITH SEBI(PIT),2015 THE TRADING WINDOW OF THE COMPANY FOR DESIGNATED PESROSN REMAIN CLOSED FROM TUESDAY 1-4-2025 TILL 48 HOURS AFTER THE ANNOUNCEMENT OF FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDING ON 31-03-2025

pdf

Colinz Laboratories Ltd.

04 Mar 2025

43.29

4.82%

Corp. Note

COLINZ LABORATORIES LTD. - 531210 - Integrated Filing (Financial)

BSE India

Pursuant to SEBI Cercular No SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31-12-2024 read with BSE circular 20250102-4, we are submitting herewith the Integrated Filing (Financial) for the Quarter and None Months Ended on 31-12-2024, Kindly take the same on records. for Colinz Labs ltd Authorized Director

pdf

Is Colinz Laboratories Ltd. worth buying?

20 Votes:

Buy 75.0%

Sell 20.0%

Hold 5.0%